TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mcpherson’S Limited ( (AU:MCP) ) has issued an update.
McPherson’s Limited has announced the appointment of Mr. John Batistich as an independent non-executive director, effective immediately. Mr. Batistich brings over 30 years of experience in marketing, digital innovation, and customer experience, having held senior roles in companies like Westfield Group and PepsiCo. His expertise is expected to support McPherson’s strategic goals and shareholder value creation. Concurrently, Jane McKellar will retire from the Board by January 2026, prompting a review of the Board’s composition and strategy alignment.
The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.
More about Mcpherson’S Limited
McPherson’s Limited is a prominent supplier of essential health, beauty, and wellness products in Australia, with a portfolio that includes iconic brands such as ‘Manicare’, ‘Lady Jayne’, ‘Dr. LeWinn’s’, ‘Swisspers’, and ‘Fusion Health’. The company focuses on expanding these brands through pharmacy, grocery, and e-commerce channels, while also offering a range of products in segments like footwear, haircare, vitamins, supplements, fragrance, and nutrition. Headquartered in Sydney, McPherson’s is listed on the Australian Securities Exchange.
YTD Price Performance: -31.25%
Average Trading Volume: 324,450
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$31.67M
Find detailed analytics on MCP stock on TipRanks’ Stock Analysis page.